Get the app!
Back to Trades
Total Value
$0
Filing Date
Jul 10, 2026
1 transaction

Trade Summary

On Jul 10, 2026, Aziz Kabeer, Insider, reported $0 of AN2 Therapeutics, Inc. (ANTX) across 1 transaction. The filing covers Common Stock and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Company Information

Ticker Symbol
ANTX
CIK
0001880438

Insider Information

Role
Insider
Location
MENLO PARK, CA

Filing Details

Filing Date
Jul 10, 2026
Transaction Date
Jul 10, 2026
Accession Number
0001193125-26-301167
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Jul 10, 2026Common Stock2,852Grant/Award

Want live alerts when Aziz Kabeer trades again?

Download Insider Trades to track ANTX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

Footnotes

  1. (F1)Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.
  2. (F2)Shares are held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). The Reporting Person is a member of the Issuer's board of directors and is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.
  3. (F3)Shares are held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. The Reporting Person is a member of the Issuer's board of directors and is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.